varicella-zoster%20virus%20infection%20(pediatric)
VARICELLA-ZOSTER VIRUS INFECTION (PEDIATRIC)
Varicella, also known as chickenpox, is a self-limited, benign disease caused by primary varicella-zoster virus (VZV) infection characterized by fever, malaise, and generalized pruritic vesicular rash.
The average incubation period is 14-16 days. It is transmitted via direct contact with vesicular fluid or inhalation of aerosolized respiratory secretions or via droplet route during face to face contact.
Hallmark sign is pruritic rash that begins in the scalp and face which eventually spreads to the trunks and extremities.

Varicella-Zoster Virus Infection (Pediatric) Drug Information

Drug Information

Indication: Vaccination against varicella in individuals ≥12 mth.

Indication: Prevention of herpes zoster (shingles) & postherpetic neuralgia; reduction of acute & chronic zoster-a...

Indication: Treatment & prevention of herpes simplex virus infections, genital herpes of skin & mucous membranes &...

Indication: Herpes simplex virus infections of skin & mucous membranes including initial & recurrent genital herpe...

Indication: Promoting resolution of acute clinical manifestations of mucocutaneous HSV infections in immunocompromised pat...

Indication: Herpes simplex skin & mucous membrane infections including initial & recurrent genital herpes. Suppres...

Indication: Treatment & prophylaxis of herpes genitalis, treatment of herpes zoster, herpes simples & varicella (c...

Indication: Active immunisation against varicella of healthy subjects ≥12 mth, susceptible high-risk patients & the...

Indication: Herpes simplex & varicella zoster infections. Herpes simplex infection prophylaxis in immunocompromised pa...

Indication: Varicella-zoster viral infections. Skin & mucous membrane infections due to herpes simplex virus. Prophyla...

1  /  3
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 5 days ago
Antiviral treatment with tenofovir alafenamide fumarate (TAF) during pregnancy in highly viraemic mothers effectively prevents mother-to-child transmission (MTCT) of hepatitis B virus (HBV) with no safety concerns, according to two studies presented during the AASLD 2020 Liver Meeting.